Scienture Holdings Inc. Files S-1 with SEC
Ticker: SCNX · Form: S-1 · Filed: Apr 4, 2025 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Scienture Holdings, Inc. (SCNX) |
| Form Type | S-1 |
| Filed Date | Apr 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, s-1, ipo-potential, pharmaceutical
TL;DR
Scienture Holdings (fka TRxADE HEALTH) filed S-1. Public offering incoming?
AI Summary
Scienture Holdings, Inc. filed an S-1 registration statement with the SEC on April 4, 2025. The company, formerly known as TRxADE HEALTH, INC., is incorporated in Delaware and has its principal executive offices in Tampa, Florida. This filing indicates a move towards public offering or significant corporate action.
Why It Matters
This S-1 filing by Scienture Holdings, Inc. signals a potential public offering or significant corporate event, which could impact investors and the pharmaceutical preparations market.
Risk Assessment
Risk Level: medium — S-1 filings often precede significant corporate events like IPOs or secondary offerings, which carry inherent market risks.
Key Numbers
- 0001382574 — Central Index Key (Unique identifier for the company in SEC filings.)
- 2834 — SIC Code (Industry classification for Pharmaceutical Preparations.)
Key Players & Entities
- Scienture Holdings, Inc. (company) — Registrant
- TRxADE HEALTH, INC. (company) — Former Company Name
- Surendra Ajjarapu (person) — Chief Executive Officer
- April 4, 2025 (date) — Filing Date
- 333-286399 (other) — SEC File Number
FAQ
What is the primary purpose of this S-1 filing for Scienture Holdings, Inc.?
The S-1 filing is a registration statement required by the SEC for companies planning to offer securities to the public, indicating a potential IPO or other public offering.
What were Scienture Holdings, Inc.'s previous names?
Scienture Holdings, Inc. was formerly known as TRxADE HEALTH, INC., TRXADE GROUP, INC., and XCELLINK INTERNATIONAL INC.
Where are Scienture Holdings, Inc.'s principal executive offices located?
The company's principal executive offices are located at 6308 Benjamin Rd, Suite 708, Tampa, Florida 33634.
When was the company incorporated?
The company was incorporated in Delaware.
Who is the Chief Executive Officer of Scienture Holdings, Inc.?
Surendra Ajjarapu is the Chief Executive Officer of Scienture Holdings, Inc.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on April 4, 2025 by Surendra Ajjarapu regarding Scienture Holdings, Inc. (SCNX).